Clinical Trials and Research Display
Trial Information |
|---|
| Title | "IMMEDIATE Trial" GLUCOSE-INSULIN-POTASSIUM (GIK) IMMEDIATE MYOCARDIAL METABOLIC ENHANCEMENT DURING INITIAL ASSESSMENT AND TREATMENT IN EMERGENCY CARE
| | Trial Identifier | CGS012 | | Sponsor | NIH | | Physicians | - Richard Herman, MD, FACEP
| | Facility | - Good Samaritan Medical Center (Recruiting)
| | Global Trial Status | Active, not recruiting | | Study Phase | Phase 2 |
|
Trial Conditions |
|---|
| Heart Attack |
|
|
Other Trial Information |
|---|
Trial Rationale and Purpose | The purpose of theis study is to determine whether giving an intravenous solution of glucose (sugar), insulin (hormone) and potassium (salt) to people who are having a definite or possible heart attack is helpful when started as soon as possible. The solution may or may not slow the damage to the heart, but if it does, other treatments may have a better chance of working. |
|